For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
In Vitro Diagnostics (IVDs) are medical devices and accessories used to perform tests on samples, (e.g., blood, urine and tissue that has been taken from the human body) in order to:
Help detect infection
Diagnose a medical condition
Prevent disease
Monitor drug therapies
Devices can range from simple tests to sophisticated DNA technology including reagents, calibrators, control materials, kits, software, and related instruments.
Scope of the Report:
This report focuses on the In Vitro Diagnostics (IVDs) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
IVD is an important segment in the global healthcare industry. The marketplace is witnessing rapid growth fuelled by technological advancements, better diagnostic tools, improved treatment monitoring, and increased availability of over-the-counter tests. IVDs add significant value to treatment processes and medical diagnoses, enhancing the well-being of the general public.
The worldwide market for In Vitro Diagnostics (IVDs) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Roche Diagnostics
- Siemens Healthcare
- Danaher Corporation
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- Johnson and Johnson
- Becton
- Dickinson and Company
- Abbott Laboratories
- Sysmex Corporation
- Diasorin S.P.A.
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Immunology
- Hematology
- Clinical Chemistry
- Molecular Diagnostics
- Coagulation
- Microbiology
- Others
Market Segment by Applications, can be divided into
- Hospital
- Laboratory
- Home Care
- Others
There are 15 Chapters to deeply display the global In Vitro Diagnostics (IVDs) market.
Chapter 1, to describe In Vitro Diagnostics (IVDs) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of In Vitro Diagnostics (IVDs), with sales, revenue, and price of In Vitro Diagnostics (IVDs), in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of In Vitro Diagnostics (IVDs), for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, In Vitro Diagnostics (IVDs) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe In Vitro Diagnostics (IVDs) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source